Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of the Effect of Two Online Interventions -Watch Your Weight During the Holidays Program and the Relative 5:2 Fasting- for the Prevention of Body Weight Gain at 8 Weeks in Mexican Adults in the Covid-19 Pandemic

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Mexican adult participants (≥20 and ≤60 years)~* Residents of the city of Hermosillo, Sonora~* Body Mass Index ≥ 23 kg/m2 and ≤ 40 kg/m2~* Availability and motivation to attend the intervention program~* Committed to not undertake any other intervention in place of, or in combination with, the one assigned in the study during the 8 weeks of the intervention~Exclusion Criteria:~* Diagnosed medical conditions that constitute a contraindication for intervention such as: diabetes, hypertension, diseases with an effect on body weight (for example: liver failure; cancer in treatment or in advanced stage; history of COVID-19 that required hospitalization, supplemental oxygen or has left sequelae that contraindicates the intervention; psychiatric conditions; eating disorders, etc.).~* Use of drugs or substances with an effect on weight, for example, metformin, orlistat, corticosteroids, etc.~* Use of addictive substances such as drugs of abuse~* Previous bariatric surgery.~* Being a participant in another intervention or treatment for the management of obesity.~* Weight loss \> 5% of total body weight in the last 4 months.~* Having plans to become pregnant within the study period, currently pregnant or breastfeeding.~* Another family member has agreed to participate in the study.~* Illiteracy.

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 60 Years
- Healthy Volunteers: t

Study Arms:
- Watch your Weight During the Holidays Program (Type: ACTIVE_COMPARATOR): None
- Relative 5:2 Fasting (Type: ACTIVE_COMPARATOR): None
- Control Group (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).